The Food and Drug Administration (FDA) has cleared the Jewel® Patch Wearable Cardioverter Defibrillator (Patch-WCD).

The US Food and Drug Administration (FDA) has approved Element Science’s premarket approval application for its Jewel Patch Wearable Cardioverter Defibrillator (Patch-WCD) intended for cardiac care.

The Jewel wearable cardioverter defibrillator system can be worn during sleep and showers, with its low-profile and water-resistant design. It includes a reusable defibrillator unit and battery ...

About the Jewel® Patch Wearable Cardioverter Defibrillator (Patch-WCD) The Jewel® Patch-WCD is a novel, water resistant wearable cardioverter defibrillator designed to detect and treat life ...

The SCD-PROTECT study adds to the body of evidence supporting LifeVest. Only LifeVest has >95% first shock success in peer-reviewed publications and real-world use, 2-5 96% one-year survival data, 6 ...

Wearable cardiac devices developer Kestra Medical Technologies has revealed plans to raise around $154m in an initial public offering (IPO). The US-based company is selling ten million common ...

Randomized controlled trials have demonstrated the superiority of implantable cardioverter-defibrillators (ICDs) to antiarrhythmic drugs in preventing sudden cardiac death. However, ICDs are not ...

Credit: Element Sciences. The system uses a proprietary algorithm to detect and classify shockable arrhythmias. The Jewel Patch-WCD is designed to be worn continuously for up to a week at a time ...

In a significant leap forward in the care of patients with cardiac disease, Element Science is proud to announce that its innovative Jewel® Patch Wearable Cardioverter Defibrillator (Patch-WCD ...